Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not be about the study. Updated the page revision from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:50:36.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The study’s outcome assessment windows and follow-up durations were updated to extend monitoring to up to about 70 months, replacing shorter timeframes. A government funding lapse notice previously shown on the page has been removed.
    Difference
    0.7%
    Check dated 2025-11-18T07:32:25.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Results for the study have been posted on the page, including a 'Results First Posted' date (2025-02-20) and related outcome data added to the study record.
    Difference
    0.3%
    Check dated 2025-10-27T21:10:38.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added a new PubMed publication entry (CheckMate 8KX pharmacokinetics/safety study) to the Publications section; no deletions or core-content changes detected.
    Difference
    3%
    Check dated 2025-10-13T12:33:04.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Summary of changes: updated operating status notice and version to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T08:27:06.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    - The page now shows a new revision: v3.1.0 in place of v3.0.2. This indicates a release/version update.
    Difference
    0.1%
    Check dated 2025-09-29T05:15:42.000Z thumbnail image

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.